The Form 4 filing, an SEC report of insider share trades, was filed on November 12, 2026. The sale took place on November 9, 2026.
Transaction details
| Transaction | |
|---|---|
| Date of Earliest Transaction | 2026-11-09 |
| Date of Latest Transaction | 2026-11-09 |
| Buy/Sell | sell |
| Transaction Count | 1 |
| Shares Transacted | 74,379 |
| Price | $20.21 |
| Total Transaction Value | $1,502,976.45 |
| Insider | |
| Ticker Symbol | CYRX |
| Company | Cryoport, Inc. |
| Insider Name | HANCOCK DANIEL M |
| Insider Title | Director |
| Sector - Industry | Industrials - Integrated Freight & Logistics |
| Holdings | |
| Total Shares Owned After Transaction | 69,052 |
| Position Size Change | 51.86% |
| Filing | |
| Filing Date | 2026-11-12 |
| SEC Link | View filing |
FAQ
What type of transaction is this?
This was a sale of Cryoport (CYRX) shares by director Daniel M. Hancock. It was reported as one transaction under code S, which identifies a sale.
What was the average price of the transaction?
The average sale price was $20.207 per share. The table shows that amount rounded to $20.21.
How did this transaction affect the insider's holdings?
The sale reduced his reported holdings by 74,379 shares, leaving 69,052 shares owned afterward. The shares sold were 51.86% of the shares he owned before the sale, based on the reported balance.
What's the total transaction value?
The reported total value was $1,502,976.453, or $1,502,976.45 rounded to cents. That amount covers the single reported sale.
Are there any special circumstances around this transaction?
The transaction information includes a Rule 10b5-1 trading-plan reference. These plans set trading instructions in advance. Footnote text and plan terms are unavailable, so it is unclear whether the reference covers this sale or the filing more broadly. The plan's start date and trading schedule are also unknown. The reference alone does not confirm that the sale met the rule's legal requirements.
For research purposes only; not investment advice.